Get started
Author

B. Parente

Observed names: B Parente, B[aacute]rbara Parente
Institution: CUF Porto Hospital
ORCID: 0000-0002-8317-2179
Observed ORCID: 0000-0002-8317-2179
OpenAlex ID: A5088625712
IMpower132: Efficacy of atezolizumab (atezo) + carboplatin (carbo)/cisplatin (cis) + pemetrexed (pem) as 1L treatment in key subgroups with stage IV non-squamous non-small cell lung cancer (NSCLC)
2018 · F. Barlesi, M. Nishio, et al. · Annals of Oncology · 51
Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation
2013 · C. Ribeiro, S. Campelos, et al. · Annals of Oncology · 51
PDF
Real-world data from the Portuguese Nivolumab Expanded Access Program (EAP) in previously treated Non Small Cell Lung Cancer (NSCLC)
2019 · A. Figueiredo, M.A. Almeida, et al. · Pulmonology · 29
PDF
Undernutrition and quality of life in non small cell lung cancer patients
2011 · S. Xará, T.F. Amaral, et al. · Revista Portuguesa de Pneumologia · 27
Desnutrição e Qualidade de Vida em Doentes com Cancro do Pulmão Não Pequenas Células
2011 · S. Xará, T.F. Amaral, et al. · Revista Portuguesa de Pneumologia · 24
PDF
An economic analysis of erlotinib, docetaxel, pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer
2008 · A. Araújo, B. Parente, et al. · Revista Portuguesa de Pneumologia · 23
Estudo da mutação do recetor do fator de crescimento epidérmico , durante 5 anos, numa população de doentes com cancro do pulmão de não pequenas células
2012 · A.S. Castro, B. Parente, et al. · Revista Portuguesa de Pneumologia · 17
PDF
Avaliação económica do erlotinib, docetaxel, pemetrexedo e tratamento de suporte no tratamento de segunda ou terceira linhas de doentes com cancro do pulmão de não pequenas células
2008 · A. Araújo, B. Parente, et al. · Revista Portuguesa de Pneumologia · 15
PDF
Epidermal Growth Factor Recetor mutation study for 5 years, in a population of patients with non-small cell lung cancer
2013 · A.S. Castro, B. Parente, et al. · Revista Portuguesa de Pneumologia · 14
Cancro do pulmão no norte de Portugal: um estudo de base hospitalar
2013 · V. Hespanhol, B. Parente, et al. · Revista Portuguesa de Pneumologia · 12
PDF
A prospective study of gemcitabine and carboplatin as first-line therapy in advanced non-small cell lung cancer: Toxicity of a three- versus a four-week schedule
2001 · B[aacute]rbara Parente, Ana Barroso, et al. · Seminars in Oncology · 12
Unresectable stage III non-small cell lung cancer: Insights from a Portuguese expert panel
2023 · A. Araújo, A. Barroso, et al. · Pulmonology · 9
Lung cancer in Northern Portugal: A hospital-based study
2013 · V. Hespanhol, B. Parente, et al. · Revista Portuguesa de Pneumologia · 8
Dermatomiosite como primeira manifestação de uma neoplasia pulmonar
2013 · A.S. Castro, A. Barroso, et al. · Revista Portuguesa de Pneumologia · 8
PDF
Cost and Burden of Non-Small Cell Lung Cancer's in Portugal
2014 · M. Borges, M. Gouveia, et al. · Value in Health · 7
PDF
Dermatomyositis as the first manifestation of a lung tumor
2013 · A. Castro, A. Barroso, et al. · Revista Portuguesa de Pneumologia · 7
A randomized phase III study of gemcitabine and carboplatinum versus vinorelbine and carboplatinum in advanced non small-cells lung cancer (NSCLC)
2000 · B Parente, A Barroso, et al. · Lung Cancer · 7
Personalizando a medicina – estratégias para implementar a avaliação do rearranjo do ‘anaplastic lymphoma kinase’ no carcinoma do pulmão de não pequenas células em Portugal
2012 · A. Araújo, A. Coelho, et al. · Revista Portuguesa de Pneumologia · 6
PDF
Personalizing medicine – strategies for implementing the evaluation of ALK rearrangement in non-small-cell lung cancer in Portugal
2012 · A. Araújo, A. Coelho, et al. · Revista Portuguesa de Pneumologia · 5
A mulher e o cancro do pulmão *
2003 · E. Teixeira, S. Conde, et al. · Revista Portuguesa de Pneumologia · 5
PDF
Diffuse vascular hamartoma with malignant behavior
2015 · I. Ladeira, S. Neves, et al. · Respiratory Medicine Case Reports · 4
PDF
Tomografia emissora de positrões: Indicações no cancro do pulmão – Experiência prospectiva de um serviço
2007 · Diva Ferreira, A. Oliveira, et al. · Revista Portuguesa de Pneumologia · 3
PDF
Chemotherapy with vlnorelblne (navelbine: NVB) + carboplatin in advanced non-small cell lung cancer (NSCLC)
1997 · B. Parente, F. Barata, et al. · European Journal of Cancer · 3
EP04.01-011 Diagnostic Approach and Treatment of Lung Cancer Patients in Portugal: Portuguese Lung Cancer Study Group Survey
2022 · F. Estevinho, A. Figueiredo, et al. · Journal of Thoracic Oncology · 2
MuTAR study, Phase II, open-label study of erlotinib (E) treatment in patients (pts) with locally advanced or metastatic non-small cell lung cancer (mNSCLC) who present activating mutations (MUT+) in the tyrosine kinase (TKI) domain of the epidermal growth factor receptor (EGFR), assessed the efficacy of 1L in Portuguese pts with mNSCLC EGFR Mut+
2016 · F. Barata, H. Queiroga, et al. · Revista Portuguesa de Pneumologia · 2
PDF
Works count: 46
Citation count: 362
H-index: 11
I10-index: 11
Year
Topic
Type